[1] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN[J]. Int J Cancer, 2010, 127(12):28932917.
[2] Goulet B, Chan G, Chambers AF, et al. An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis[J]. Biochem Cell Biol, 2012,90(1):2238.
[3] Berardi R, Morgese F, Onofri A, et al. Role of maspin in cancer[J]. Clin Transl Med,2013,2(1):13261328.
[4] Bailey CM, KhalkhaliEllis Z, Seftor EA, et al. Biological functions of maspin[J]. J Cell Physiol, 2006,209(3):617624.
[5] Choy B, FindeisHosey JJ, Li F, et al. High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung[J]. Int J Clin Exp Pathol, 2013, 6(11):25422547.
[6] Zheng AH, Yi YF, Zhou WW. Construction of a eukaryotic vector expressing MASPIN gene and its effect on cell apoptosis in gastric cancer cell line SGC7901[J].Ai Zheng, 2008, 27(11):11611165.
[7] 倪江涛, 石海鹏, 易永芬. RNA干扰maspin基因对胃癌细胞株MKN28凋亡的影响[J]. 肿瘤, 2010,30(7):571573.
[8] Cesca M, Bizzaro F, Zucchetti M, et al. Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents[J]. Front Oncol, 2013, 3:259.
[9] Sakurai T, Kudo M. Signaling pathways governing tumor angiogenesis[J]. Oncology, 2011, 81(1):2429.
[10] 白玉贤, 易继林, 王树叶. 胃癌组织中Maspin蛋白与血管内皮生长因子C的表达及其相关性肿瘤[J]. 肿瘤防治研究, 2007, 34(8):6063.
[11] Okayama H, Kumamoto K, Saitou K, et al. CD44v6, MMP7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer[J]. Oncol Rep, 2009, 22(4):745755.
[12] Yang Y, Shi H, Li X, et al. Effects of shRNA targeting maspin on invasion of gastric carcinoma SGC7901 cell line[J]. Oncol Rep, 2011, 25(1):259265.
[13] Ito R, Nakayama H, Yoshida K, et al. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality[J]. Oncol Rep, 2004, 12(5):985890.
[14] Oshiro MM, Watts GS, Wozniak RJ, et al. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression[J]. Oncogene, 2003, 22(23):36243634.
[15] Bodenstine TM, Seftor RE, KhalkhaliEllis Z, et al. Maspin: molecular mechanisms and therapeutic implications[J]. Cancer Metastasis Rev,2012,31(34):529551.
[16] Lockett J, Yin S, Li X, Meng Y, et al. Tumor suppressive maspin and epithelial homeostasis[J]. J Cell Biochem, 2006, 97(4):651660. |